Basic Information
Arxx Therapeutics is a biotechnology company founded by scientists and drug developers. Arxx Therapeutics has developed a first-class monoclonal antibody with a unique mechanism of action targeting non-lytic tissue fibrosis.
Arxx Therapeutics AS
The Kingdom of Norway
15~50 people
January 01, 2018
--
--
Enterprise Profile
Industrial Sector
Concept
Application Scenarios